Chemical drugs and formulations / Biomedicine and medical devices / Complete systems and use-case applications Sub-industry and Supply-chain Study

Filter-difference study

Against the 200-record Chemical Pharma Preparation Keyword Candidate Study, this 143-record cohort shares 143 records. Only 0 occur here and 57 only in the reference; the union contains 200. These are filter-membership differences, not company entries or exits.

An ID-deduplicated archive snapshot, not the whole market, current recognition or operating results.

The largest recorded industry participation gap is for Biomedicine: 143/143 here versus 184/200 in the reference, an absolute difference of 8.0 percentage points. The cohorts have overlapping company IDs and are not independent samples.

Zero means no recorded label, not no business; multi-label cells overlap.

Multi-label counts can overlap; filter compliance is not industrial advantage.

Existing excerpts do not certify entire old reports; list linkage is not final recognition. Full definitions are on the series page.

Shared records with Chemical Pharma Preparation Keyword Candidate Study: 143; records in this cohort but outside that set: 0. The intersection/union ratio is 71.5%, a measure of label overlap rather than business collaboration. Read comparison

Shared records with Peptide Drug CDMO Keyword Candidate Study: 40; records in this cohort but outside that set: 103. The intersection/union ratio is 24.5%, a measure of label overlap rather than business collaboration. Read comparison